Anixa Biosciences, Inc.

NASDAQ: ANIX    
Share price (9/18/20): $2.58    
Market cap (9/18/20): $61.4 million

Material Contracts Filter

EX-10.1
from 10-Q 15 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Collaboration Agreement
12/34/56
EX-10.2
from 10-Q ~5 pages Amendment 1 to the Collaboration Agreement Between Certainty Therapeutics, Inc. and H. Lee Moffitt Cancer Center and Research Institute, Inc
12/34/56
EX-10.1
from 10-Q 40 pages Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement Between the Cleveland Clinic Foundation and Anixa Biosciences, Inc. Dated as of July 8, 2019 Redactions With Respect to Certain Portions Hereof Denoted With “***” Exclusive License Agreement
12/34/56
EX-10.1
from S-3 41 pages Anixa Biosciences, Inc. Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.1
from 8-K 43 pages ITUS Corporation Common Stock
12/34/56
EX-10.15
from 10-K 23 pages Irs Employer Identification No. 11-2622630
12/34/56
EX-10.14
from 10-K 39 pages Irs Employer Identification No. 11-2622630
12/34/56
EX-10.1
from 8-K 49 pages ITUS Corporation Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.1
from 8-K 7 pages ITUS Corporation Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.1
from 8-K 25 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 29 pages Dealer-Manager Agreement
12/34/56
EX-10.21
from 10-K 1 page ITUS Corporation October 17, 2016
12/34/56
EX-10.20
from 10-K 8 pages Payment of Principal and Interest; Method of Payment
12/34/56
EX-10.19
from 10-K 6 pages Letter Agreement
12/34/56
EX-10.1
from 8-K 26 pages ITUS Corporation Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-10.2
from 8-K 10 pages Patent Assignment Agreement
12/34/56
EX-10.1
from 8-K 20 pages Settlement Agreement
12/34/56
EX-10.22
from S-1 9 pages Warrant to Purchase 9,249,472 Shares ITUS Corporation Common Stock Purchase Warrant
12/34/56
EX-10.21
from S-1 13 pages Debt Conversion Agreement
12/34/56
EX-10.20
from S-1 43 pages Termination Agreement
12/34/56